Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights
GlobeNewswire
- Interim data from SEAPORT-1, a Phase 1 trial of INZ-701 in patients with end-stage kidney disease receiving hemodialysis, on..
- Interim data from SEAPORT-1, a Phase 1 trial of INZ-701 in patients with end-stage kidney disease receiving hemodialysis, on..
*Elevating Fitness Performance and Recovery*
*OCALA, FL / ACCESSWIRE / January 30, 2024 / *Fortifeye Fit Pro, the latest..
The growing resistance of microbes to different drugs is one of the significant factors influencing the antibiotic susceptibility..